Modified Bismuth Nanoparticles: A New Targeted Nanoprobe for Computed Tomography Imaging of Cancer
Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptore...
Saved in:
Published in | Cell journal (Yakhteh) Vol. 24; no. 9; pp. 515 - 521 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Tehran
Royan Institute of Iran
01.09.2022
Royan Institute (ACECR), Tehran |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging. Materials and Methods: In this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPs was characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriate concentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) of targeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tube voltages of 90, 120 and 140 kVp. Results: We showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxic in a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were 1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNR values at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively. Conclusion: These findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be applied as a good contrast medium for molecular CT techniques. |
---|---|
AbstractList | OBJECTIVERecently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging. MATERIALS AND METHODSIn this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPs was characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriate concentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) of targeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tube voltages of 90, 120 and 140 kVp. RESULTSWe showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxic in a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were 1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNR values at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively. CONCLUSIONThese findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be applied as a good contrast medium for molecular CT techniques. Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computedtomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelinpeptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging.Materials and Methods: In this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPswas characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriateconcentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) oftargeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tubevoltages of 90, 120 and 140 kVp.Results: We showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxicin a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNRvalues at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively.Conclusion: These findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be appliedas a good contrast medium for molecular CT techniques. Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging. Materials and Methods: In this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPs was characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriate concentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) of targeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tube voltages of 90, 120 and 140 kVp. Results: We showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxic in a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were 1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNR values at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively. Conclusion: These findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be applied as a good contrast medium for molecular CT techniques. |
Author | Mohammadi, Milad Khademi, Sara Keshtkar, Mohammad Irajirad, Rasoul Choghazrdi, Yazdan Montazerabadi, Alireza |
Author_xml | – sequence: 1 givenname: Milad surname: Mohammadi fullname: Mohammadi, Milad – sequence: 2 givenname: Sara surname: Khademi fullname: Khademi, Sara – sequence: 3 givenname: Yazdan surname: Choghazrdi fullname: Choghazrdi, Yazdan – sequence: 4 givenname: Rasoul surname: Irajirad fullname: Irajirad, Rasoul – sequence: 5 givenname: Mohammad surname: Keshtkar fullname: Keshtkar, Mohammad – sequence: 6 givenname: Alireza surname: Montazerabadi fullname: Montazerabadi, Alireza |
BookMark | eNpdkL1PwzAQxS1UJErpzmiJhaXFvji2w1YqPiqVspQ5cuJzmqqJi5MI9b8nbREDt9zp3dOTfu-aDGpfIyG3nE0BmBIPOe522ykwgKmOhL4gQwDQk1hzMfi7mbwi46bZsn4kA57AkGTv3pauREufyqbq2g1dmdrvTWjLfIfNI53RFX7TtQkFtr3r9A0-Q-p8oHNf7bujvPaVL4LZbw50UZmirAvqHZ2bOsdwQy6d2TU4_t0j8vnyvJ6_TZYfr4v5bDmxIOJ2kmiO3LKI5w4y0Do2XDEds0QAk3nupFYykegAnZVO5gwUR6U0UyZWmc2jEVmcc60323QfysqEQ-pNmZ4EH4r0Fyu1EUoAoThTmUC0iYbMSmbiSGuhTNJn3Z-zetavDps2rcrmWLKp0XdNCgr6aoViqrfe_bNufRfqnjQFHfUEMQgR_QDNg3_s |
ContentType | Journal Article |
Copyright | 2022. This work is published under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022. This work is published under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 3V. 7QL 7T5 7TM 7TO 7U9 7X7 7XB 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU CWDGH DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M7N M7P P64 PIMPY PQEST PQQKQ PQUKI RC3 7X8 DOA |
DOI | 10.22074/cellj.2022.8348 |
DatabaseName | ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Middle East & Africa Database ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition Genetics Abstracts MEDLINE - Academic Directory of Open Access Journals |
DatabaseTitle | Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest Central Genetics Abstracts Health Research Premium Collection Middle East & Africa Database Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2228-5814 |
EndPage | 521 |
ExternalDocumentID | oai_doaj_org_article_d3e62247107b4eed982bd60a538847a9 |
GroupedDBID | --- 3V. 5VS 7QL 7T5 7TM 7TO 7U9 7X7 7XB 8FD 8FE 8FH 8FI 8FJ 8FK AAKDD ABDBF ABUWG ACPRK ADBBV AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C1K CCPQU CWDGH DIK DWQXO EBD EOJEC ESX FR3 FYUFA GNUQQ GROUPED_DOAJ H94 HCIFZ HMCUK K9. KQ8 LK8 M48 M7N M7P OBODZ OK1 P64 PGMZT PIMPY PQEST PQQKQ PQUKI PROAC RC3 RNS RPM TUS UKHRP 7X8 |
ID | FETCH-LOGICAL-d245t-981e1d031cf2b2885a17085094206ccf687696ef2efd6f6c0271e77807a57bdc3 |
IEDL.DBID | 7X7 |
ISSN | 2228-5806 |
IngestDate | Tue Oct 22 15:14:42 EDT 2024 Fri Aug 16 22:46:27 EDT 2024 Thu Oct 10 21:58:53 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-d245t-981e1d031cf2b2885a17085094206ccf687696ef2efd6f6c0271e77807a57bdc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2830855244?pq-origsite=%requestingapplication% |
PQID | 2830855244 |
PQPubID | 105750 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d3e62247107b4eed982bd60a538847a9 proquest_miscellaneous_2728144707 proquest_journals_2830855244 |
PublicationCentury | 2000 |
PublicationDate | 2022-09-01 |
PublicationDateYYYYMMDD | 2022-09-01 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Tehran |
PublicationPlace_xml | – name: Tehran |
PublicationTitle | Cell journal (Yakhteh) |
PublicationYear | 2022 |
Publisher | Royan Institute of Iran Royan Institute (ACECR), Tehran |
Publisher_xml | – name: Royan Institute of Iran – name: Royan Institute (ACECR), Tehran |
SSID | ssj0000602192 |
Score | 2.3023512 |
Snippet | Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a... OBJECTIVERecently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a... Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computedtomography (CT) imaging of cancer cells stays a... |
SourceID | doaj proquest |
SourceType | Open Website Aggregation Database |
StartPage | 515 |
SubjectTerms | Attenuation Bismuth Bismuth sulfides Cancer Computed tomography Contrast agents Contrast media ct contrast agents Cytotoxicity Medical imaging molecular imaging Nanoparticles targeted imaging Tomography Toxicity testing triptorelin X ray tubes |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS8MwFA6ykxdRpzidEkG81bVJ86Pe5nBMQU8b7FaSJsEJbWXrDv73vqRVBh68eG1CSfPe-9576cv3ELoBr-B4IVwEroBHKXjcSHNFI6oLLVJFGXWh2uKVzxbp85Itd1p9-Zqwlh643biRoZbDC8ERCp0CoGeSaMNjBYYKwKraq3txtpNMtRgMvit0RPYnHBGTcfePkhDwmSN_KP4OySEhd5L61j-Br_8XHAcfMz1EB11wiMftoo7Qnq2OUX9cQWJcfuJbHMo1wzl4H-mX2qwcBJD4YbUpt80bBqCEDLgrdLvHYwwAhueh0htmhVF_9wdDmIq7Zg4Gz-uyI63GT2XoWIRrhydeF9YnaDF9nE9mUdcwITIkZU2UycQmBsy0cEQTKZlKhKeky1IS86JwHKAv49YR6wwHEUFKmlghZCwUE9oU9BT1qrqyZwgn3KaOUqMTBUGfyJQ1xCptmdGOZKkaoAe_ZflHy4mRe5bq8ABkl3efmv8luwEafm943pnOJveMZJIxCDsG6PpnGJTeC01Vtt7CHEEkZIIiFuf_sY4LtO91oS0dG6Jes97aS4g1Gn0V1OoLaKTPXQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA4-Ll7EJ64vIoi3apt3BZFVFBX0tAveStIkPnBb3Qfov3eSjXpQvDYl0Mxkvm_SLzMI7QMqeFFLnwEUiIwB4mZGaJpRUxvJNOXUR7XFnbjqs5t7fv9zPTot4OjP1C70k-oPXw7f3z5OYcOfBBkzAQg8Cmfcz5DrEXKoKFOzaJ4wyNODkC-R_WlcBjyLXZLDqUfGVZ7-W_45Sarh_ytER9y5XEKLiTDi7tTCy2jGNStotdtAsjz4wAc4Sjjj2fgqMretffJAKvHZ02gwGT9iCJ6QFSfx2zHuYghquBfV3_BWHA33gTBQV5waPFjcawepkDW-HsQuRrj1-Dz4x3AN9S8veudXWWqikFnC-DgrVeEKC1u39sQQpbguZChTVzKSi7r2AsJhKZwnzlsBZoM0tXBSqlxqLo2t6Tqaa9rGbSBcCMc8pdYUGoigLLWzxGnjuDWelEx30FlYsup1WiejCpWr44N2-FClT60sdQIcBIiNNAwAulTEWJFrCLwAlLrsoO2vBa--vKEKVcoU50BFOmjvexg2QjCablw7gXckUZAdylxu_j_FFloIVp4KxbbR3Hg4cTvALMZmNzrMJ9k_ywQ priority: 102 providerName: Scholars Portal |
Title | Modified Bismuth Nanoparticles: A New Targeted Nanoprobe for Computed Tomography Imaging of Cancer |
URI | https://www.proquest.com/docview/2830855244 https://search.proquest.com/docview/2728144707 https://doaj.org/article/d3e62247107b4eed982bd60a538847a9 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELba5dJLBaVVt8DKSFVvLonf6QXtboEFCVRVi7q3yI5tCtImsI9D_z1jr5ceKvWSSLEVKZ7x982MJzMIfQZWCLJRgQAVSMKBcYmVhhFmG6u4YYKFlG1xIye3_GomZjngtsxplVtMTEDtuibGyE9ioSotBLDR6eMTiV2j4ulqbqHxGu2UtJAxpUvN1EuMpZDAYKkvcoxzEKGLfFJJKTDnSQyNP4CLSOlXzWIDoFS1_x9QTkxzvoveZhMRDzcy3UOvfPsO7Q9bcI_nf_AXnJI2UzR8H9nrzt0HMCPx6H45X69-Y4BL8INzuts3PMQAY3ia8r1hVhqNfwBhMFZxbung8LSb59LV-HKe-hbhLuBx1IjFe3R7fjYdT0hum0Ac5WJFKl360sFmbQK1VGthShUL01UclqhpggQArKQP1AcnQVDgmJZeKV0oI5R1DfuAem3X-o8Il9LzwJizpQHTT1XGO-qN9cLZQCtu-mgUl6x-3FTGqGOt6vSgW9zV-VNrx7wElQBTRlkOlFxpap0sDEAtUKOp-uhwu-B13kDL-q-4--j4ZRhUPwrNtL5bwxxFNfiDqlCf_v-KA_QmSnmTGnaIeqvF2h-BLbGyg6QwA7QzOrv58RPu41_fLyaD5JnD9ZrrZ5cAzGg |
link.rule.ids | 315,783,787,867,2109,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTxsxELUKPZRLVUoRKQFcCXFz2bXXH9sLCggU2iSnRMptZa9tmkrZhXwc-PeMHZMekLiurZXWY8-bGc--h9A5oIIXtfQEoECQAhCXGKEZYaY2stCMMx-7LUaiPyl-T_k0FdyWqa3y1SdGR23bOtTILwNRleIc0Ojq8YkE1ahwu5okNHbQx8DDFRQM5FRuayyZAASLusihzkG4ytJNJaWAnJehNP4PUkRKfyoWBIAia_8bpxyR5u4L-pxCRNzb2HQffXDNV3TQayA9nj_jCxybNmM1_ACZYWtnHsJIfD1bztervxjcJeTBqd3tF-5hcGN4HPu9YVYcDX8AYQhWcZJ0sHjczhN1Nb6fR90i3Hp8E3bE4hua3N2Ob_okySYQSwu-IqXKXW7hsNaeGqoU17kMxHRlQTNR116AAyyF89R5K8BQkJjmTkqVSc2lsTU7RLtN27gjhHPhCs-YNbmG0E-W2lnqtHHcGk_LQnfQdViy6nHDjFEFrur4oF08VOlTK8ucgC0BoYw0BUByqaixItPgagEaddlB3dcFr9IBWlb_zd1BP7bDsPWD0XTj2jXMkVRBPigz-f39V5yhT_3xcFAN7kd_jtFesPimTayLdleLtTuBuGJlTuPmeQHykcpW |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELboIlW9VC1QdQu0Rqq4uZv4nV7QLmUFFFaoWiRukR3blEqbwD4O_PuOvQYOlXqNrUjxPL6Z8ZcZhL4CKgTZqEAACiThgLjESsMIs41V3DDBQmJbTOTpNT-_ETeZ_7TItMonn5gcteuaWCMfxEZVWghAo0HItIirH-Oj-wcSJ0jFm9Y8TuMV2lRcsqKHNkcnk6tfzxWXQgKepSnJsepBhC7yvSWlgKODWCj_Awkjpd80i-OAUg__f1x0wp3xO_Q2B4x4uJbwe7Th2y20PWwhWZ494kOcKJypNr6N7GXn7gIElXh0t5itlr8xOE_IijP57TseYnBqeJrY37Arrcb_gTCErjgPeHB42s1yI2t8NktTjHAX8HHUj_kOuh6fTI9PSR6iQBzlYkkqXfrSgek2gVqqtTClim3qKk4L2TRBgjuspA_UBydBbJCmll4pXSgjlHUN-4B6bdf6jwiX0vPAmLOlgUBQVcY76o31wtlAK276aBSPrL5f98moY-fq9KCb39b5U2vHvAQFgcBGWQ4AXWlqnSwMOF4ASlP10d7TgdfZnBb1i_D76OB5GQwhCs20vlvBHkU1ZIeqUJ_-_4ov6DVoTn1xNvm5i95Ega85Y3uot5yv_D4EGUv7OWvPX9k2z_M |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modified+Bismuth+Nanoparticles%3A+A+New+Targeted+Nanoprobe+for+Computed+Tomography+Imaging+of+Cancer&rft.jtitle=Cell+journal+%28Yakhteh%29&rft.au=Mohammadi%2C+Milad&rft.au=Khademi%2C+Sara&rft.au=Choghazrdi%2C+Yazdan&rft.au=Irajirad%2C+Rasoul&rft.date=2022-09-01&rft.pub=Royan+Institute+of+Iran&rft.issn=2228-5806&rft.eissn=2228-5814&rft.volume=24&rft.issue=9&rft.spage=515&rft_id=info:doi/10.22074%2Fcellj.2022.8348&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2228-5806&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2228-5806&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2228-5806&client=summon |